Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Premenstrual syndrome.

Helmerhorst FM, Lopez LM, Kaptein AA.

Lancet. 2008 Aug 9;372(9637):446; author reply 446-7. doi: 10.1016/S0140-6736(08)61191-5. No abstract available.

PMID:
18692709
2.

Hormonal contraceptives for acne management.

Rich P.

Cutis. 2008 Jan;81(1 Suppl):13-8. Review.

PMID:
18338653
3.

The new extended regimen for the management of premenstrual symptoms needs to be properly assessed.

Marasinghe JP, Don CK, Amarasinghe AA.

Am J Obstet Gynecol. 2007 Oct;197(4):436; author reply 436-7. No abstract available.

PMID:
17904994
4.

[The position of drospirenone in premenstrual syndrome teratment].

Havlín M.

Ceska Gynekol. 2006 Jan;71(1):70, 72-3. Review. Czech.

PMID:
16465920
5.

A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.

Brown C, Ling F, Wan J.

J Reprod Med. 2002 Jan;47(1):14-22.

PMID:
11838304
6.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein AA, Helmerhorst FM.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006586. doi: 10.1002/14651858.CD006586.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD006586.

PMID:
19370644
7.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein A, Helmerhorst FM.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006586. doi: 10.1002/14651858.CD006586.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD006586.

PMID:
18254106
8.

[Jangee – young, free and beautiful].

Velev P.

Akush Ginekol (Sofiia). 2012;51 Suppl 1:47. Bulgarian. No abstract available.

PMID:
23236681
9.

[Extracontraceptive benefits of EE/DRSP (Yaz) in 24+4 day regimen].

Bruni Bresciani V.

Minerva Ginecol. 2010 Jun;62(3):261-6. Review. Italian.

PMID:
20595950
10.
11.

Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives.

Coffee AL, Kuehl TJ, Sulak PJ.

Pharmacotherapy. 2008 May;28(5):576-83. doi: 10.1592/phco.28.5.576.

PMID:
18447656
12.

Drospirenone, a progestogen with antimineralocorticoid properties: a short review.

Oelkers W.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):255-61. Review.

PMID:
15134826
13.

Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.

Coffee AL, Kuehl TJ, Willis S, Sulak PJ.

Am J Obstet Gynecol. 2006 Nov;195(5):1311-9. Epub 2006 Jun 21.

PMID:
16796986
14.

An oral contraceptive with 3 approved indications.

Mishell DR Jr.

J Reprod Med. 2008 Sep;53(9 Suppl):717-9. No abstract available.

PMID:
18980043
15.

Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.

Freeman EW.

Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 3:27-34; discussion 42-3.

PMID:
12659404
16.

YAZ in the treatment of premenstrual dysphoric disorder.

Rapkin AJ.

J Reprod Med. 2008 Sep;53(9 Suppl):729-41.

PMID:
18980045
17.

Drospirenone: a novel progestin.

Rapkin AJ, Winer SA.

Expert Opin Pharmacother. 2007 May;8(7):989-99. Review.

PMID:
17472544
18.
19.

Letter: Oral contraceptives and premenstrual tension.

Mears E.

Br Med J. 1975 Nov 15;4(5993):408. No abstract available.

20.

ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives.

[No authors listed]

Obstet Gynecol. 2010 Jan;115(1):206-18. doi: 10.1097/AOG.0b013e3181cb50b5. No abstract available.

PMID:
20027071

Supplemental Content

Support Center